Phathom Pharmaceuticals Statistics
NASDAQ: PHATHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.81+0.03 (+0.44%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 6.80 -0.15%
Phathom Pharmaceuticals by the numbers
Phathom Pharmaceuticals has a market capitalization of $550.9 million based on 80.90M shares outstanding. With trailing EPS of $-1.26, Phathom Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.0% below its 50-day average and 39.8% below its 200-day average.
Average daily trading volume is 1.39M shares, or about $9.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PHAT valuation vs. peer median
| Metric | PHAT | Peer median | Difference |
|---|---|---|---|
| Market cap | $550.94M | $558.99M | -1% |
| Avg. volume | 1.39M | 561.96K | +148% |
Peer median across 8 companies: CTMX, MNPR, CRMD, STTK, BLSM, EVO, OCS, MPLT.
Valuation
- Market cap
- $550.94M
- Forward P/E
- 6.33
- EPS (TTM)
- $-1.26
- Shares outstanding
- 80.90M
Price and trading
- Previous close
- 6.78
- Open
- 6.76
- Day range
- 6.64 – 7.03
- 52-week range
- 6.52 – 18.31
- 52-week change
- -37.18%
- Beta
- —
- Volume
- 1.63M
- Average volume
- 1.39M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 550.94M
- Forward Pe
- 6.33
- Eps
- -1.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.31
- Week52 Low
- 6.52
- Avg Volume
- 1.39M
- Shares Outstanding
- 80.90M
- Ma50
- 8.52
- Ma200
- 11.32
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -62.81%
- Pct From52w Low
- 4.45%